Tuberculosis (TB) is a disease affecting the population across the world. Although tuberculosis is a curable disease, it still remains one of the most common causes of death among adults, particularly in the emerging economies.
This report contains market size and forecasts of Anti-tuberculosis Therapeutics in Global, including the following market information:
Global Anti-tuberculosis Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anti-tuberculosis Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Isoniazid Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-tuberculosis Therapeutics include Lupin, Macleods Pharmaceuticals, Otsuka Pharmaceutical, Johnson & Johnson, Pfizer, Novartis, Abbott, AstraZeneca and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-tuberculosis Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-tuberculosis Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anti-tuberculosis Therapeutics Market Segment Percentages, by Type, 2021 (%)
Isoniazid
Rifampin
Ethambutol
Pyrazinamide
Otherr
Global Anti-tuberculosis Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anti-tuberculosis Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospitals and Clinics
Government Agencies
Non-Profit Organizations
Others
Global Anti-tuberculosis Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anti-tuberculosis Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-tuberculosis Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anti-tuberculosis Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lupin
Macleods Pharmaceuticals
Otsuka Pharmaceutical
Johnson & Johnson
Pfizer
Novartis
Abbott
AstraZeneca
Bayer
Eli Lilly
GlaxoSmithKline
Merck
Sanofi